OpenLegislation

The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No.2) Regulations 2015 in England

S.I. 2015/1430 · Made 25 June 2015

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

National Health Service, England

Made 25th June 2015

Laid before Parliament 1st July 2015

Coming into force 1st October 2015

The Secretary of State for Health makes the following Regulations in exercise of the powers conferred by sections 6E and 272(7) and (8) of the National Health Service Act 2006f1.

Annotations to the whole text

Footnotes

f1

2006 c.41. Section 6E was inserted by section 20 of the Health and Social Care Act 2012 (c.7). Powers exercised in making these Regulations are exercisable by the Secretary of State in relation to England only (see section 271(1)). See section 275(1) for the definition of “regulations”.

Contents

  1. 1Citation, commencement and interpretation
  2. 2Amendments in relation to Standing Rules: NHS Continuing Healthcare and NHS funded nursing care
  3. 3Amendments in relation to Standing Rules: waiting times
  4. 4Amendment in relation to Standing Rules: duty to have regard to guidance
  5. Signature
  6. Explanatory note

1Citation, commencement and interpretation

(1)

These Regulations may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) (No.2) Regulations 2015 and come into force on 1st October 2015.

(2)

In these Regulations, “the principal Regulations” means the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012f1.

2Amendments in relation to Standing Rules: NHS Continuing Healthcare and NHS funded nursing care

In regulation 20 of the principal Regulationsf1 (interpretation)—

(a)

in the definition of “flat rate payment”, for “£110.89” substitute “£112”;

(b)

in the definition of “high band payment”, for “£152.61” substitute “£154.14”.

3Amendments in relation to Standing Rules: waiting times

(1)

Regulation 45 of the principal Regulations (duty to meet the maximum waiting time standards) is amended as follows.

(2)

Omit paragraphs (1) and (2).

(3)

In paragraph (3), after “commence” insert “appropriate”.

(4)

Omit paragraphs (5) and (6).

4Amendment in relation to Standing Rules: duty to have regard to guidance

In regulation 50 of the principal Regulationsf1 (duty to have regard to guidance), for ““The Referral to Treatment Consultant-led Waiting Times Rules Suite dated April 2014”” substitute ““The Referral to Treatment Consultant-led Waiting Times Rules Suite dated October 2015””f2.

Signature

Signed by authority of the Secretary of State for Health.

Prior

Parliamentary Under-Secretary of State

Department of Health

25th June 2015

Explanatory note

(This note is not part of the Regulations)

These Regulations amend the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I.2012/2996).

The amendments made by regulation 2 increase the rates for NHS-funded Nursing Care payable by the relevant body (the National Health Service Commissioning Board or a clinical commissioning group).

The amendments made by regulation 3 remove the reference to the Referral to Treatment operational standards for NHS treatment which has commenced so that the only remaining standard is that 92% of patients on incomplete pathways should have been waiting no more than 18 weeks from referral.

The amendment made by regulation 4 reflects the fact that because of the amendments made by regulation 3, it is necessary to update “The Referral to Treatment Consultant-led Waiting Times Rules Suite” which a relevant body must have regard to in carrying out its duties. The existing Rules Suite is updated with effect from 1st October 2015.

An impact assessment has not been produced for this instrument as minimal impact on business or the private or voluntary sector is foreseen.